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The occurrence of contrast induced nephropa-
thy (CIN) remains one of the gravest complications 
of percutaneous coronary intervention (PCI) and 
is related to increased morbidity and mortality 
[1, 2]. In select cases renal replacement therapy 
is required, increasing the rate of major adverse 
events [3]. Minimizing contrast administration and 
optimal fluid management are effective in preven-
tion [4], but in select patients a minimal quantity of 
contrast may lead to CIN. Since indicated the first 
feasibility reports [5–7], the concept of intravas-
cular ultrasound (IVUS) guided PCI has become 
appealing for patients at risk of CIN. Presented 
herein, is a series of IVUS-guided PCI cases with 
ultra-low contrast volume angiographic control.
The procedure protocol is as follows. Hy-
drophobic guidewires are placed in main vessel 
and major sidebranches. Intraluminal position is 
IVUS-verified. “Dry-cine” positioning of IVUS and 
ultrasound imaging are co-registered to select op-
timal strategy. The effect of main vessel stenting is 
assessed with control IVUS pullbacks. Should a side 
branch compromise be suspected, the vessel is re-
wired and physiological assessment is performed. In 
order to achieve optimal imaging quality, HD-IVUS 
is the preferred imaging modality. Post-procedural 
transthoracic echocardiography is performed to ex-
clude pericardial effusion. Bail-out contrast admin-
istration is acceptable yet remains the last resort. 
Thus, this protocol admits the administration of 
a minimal quantity of contrast media mixed 1:1 with 
saline for post-procedural ultra-low contrast angio-
graphic verification only, at the operator’s discretion. 
The acceptable quantity of contrast is calculated 
from MDRD estimated glomerular filtration rate 
(eGFR) as follows: x mL of contrast = eGFR/2. The 
maximum quantity actually administered per patient 
in the following case series was 4 mL.
Patient 1. A 72-year-old male with chronic 
kidney disease (CKD) stage 4 was admitted with 
non-ST-segment elevation myocardial infarction 
(NSTEMI). Echocardiography showed moderate 
left ventricular systolic dysfunction (left ventricu-
lar ejection fraction [LVEF] 42%), eGFR was 20.9 
mL/min/1.73 m2). Coronary angiography showed 
multivessel disease (MVD), with diffuse lesions in 
left anterior descending artery (LAD), obtuse mar-
ginal branches (OM1, OM2) and significant aorto-
ostial in right coronary artery (RCA) (Fig. 1A, B). 
Within 24 h CIN had developed, with oliguria and 
an eGFR drop to 16 mL/min/1.73 m2. This was 
treated with hydration. The patient was quali-
fied for coronary artery bypass grafting (CABG). 
Due to scarce venous material the RCA was not 
grafted and qualified for “zero contrast” PCI. The 
artery was wired with a hydrophobic wire. IVUS 
confirmed diffuse significant stenosis originating 
in the ostium (Fig. 1C, D). Dry cine of the IVUS 
sensor was acquired at plaque origin. Direct stent-
ing with a 3.5 × 29 sirolimus eluting stent was 
performed with post-dilation of the ostium. Control 
IVUS pullback confirmed proper deployment and 
apposition of the stent. One control contrast injec-
tion was performed (4 mL saline and 4 mL of con-
trast) to confirm the findings of IVUS (Fig. 1E, G). 
Further in-hospital stay was uneventful. The pa-
tient was discharged on the second day post-PCI 
with no signs of CIN.
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Patient 2. A 74-year-old female, with numer-
ous comorbidities (diabetes, stage IV CKD — 
eGFR on admission 26 mL/min/1.73 m2, Leriche 
syndrome), was admitted after an NSTEMI com-
plicated with pulmonary edema. Echocardiography 
revealed an LVEF of 48% with no valvular disease. 
The patient was initially qualified for CABG, how-
ever after re-assessment (dubious ostial left main 
lesion, diffuse critical stenoses of the RCA) the pa-
tient was qualified for IVUS-guided PCI. The signif-
icance of ostial left main lesion was excluded (mini-
mal lumen area [MLA] 8.8 mm2). As IVUS catheter 
introduction to the RCA was impossible, numerous 
predilations were performed (Fig. 2A, B). IVUS 
pullback revealed diffuse, calcified lesions with 
a dissection in mid-RCA (Fig. 2C, D). A “mother 
and child” catheter was introduced to the distal part 
of the vessel and 3 everolimus eluting stents (EES) 
were implanted (3.5 × 38; 3.5 × 33; 4.0 × 28; 
Fig. 2E, F). Control IVUS pullback showed stent 
underexpansion in the mid and distal RCA. Post-
dilation with 3.0 and 4.0 non-compliant balloon re-
sulted in an optimal IVUS result (Fig. 2G, H). How-
ever, the patient presented with chest pain. Control 
echo showed good contractility and no pericardial 
effusion. A single contrast injection was performed 
(4 mL of contrast mixed with 4 mL of saline), 
confirming optimal PCI result, identifying 2 small 
Figure 1. Intravascular ultrasound-guided percutaneous coronary intervention. 1A–G. Case 1; 2A–H. Case 2; 3A–R. 
Case 3; 4A–F. Case 4.
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(< 1 mm) occluded side branches of the RCA. 
Further in-hospital stay was uneventful and the 
patient was released 4 days after the procedure.
Patient 3. A 75-year-old male with hyper-
tension and diabetes was admitted with Canadian 
Cardiovascular Society (CCS) III angina. Echocar-
diography showed very good LVEF with no valvular 
disease. Coronary angiography revealed MVD 
with critical RCA lesions, significant circumflex 
artery (Cx) lesions and diffuse LAD lesions (LAD 
FFR 0.89). Ad hoc RCA PCI with 1 EES was per-
formed (Fig. 3A–E). After the procedure (130 mL 
of contrast media) CIN was diagnosed and treated 
with i.v. fluids (creatinine levels 113 Æ 147 Æ 117 
µmol/L). The patient qualified for a second stage 
procedure. On readmission (after 3 months) de-
terioration of renal function was observed (eGFR 
28 mL/min/1.73 m2) with no improvement after 
6 days of hydration. The patient qualified for IVUS- 
-HD assessment of the RCA and IVUS-HD guided 
zero contrast Cx PCI. IVUS-HD of RCA showed op-
timal effect of prior PCI (Fig. 3F, G). Cx was wired 
with a hydrophobic wire. IVUS showed diffuse 
obstructive CAD (Fig. 3H–K). OM1 was wired. Bal-
loon angioplasty with a 2.5 × 30 mm catheter was 
performed (Fig. 3L). IVUS pullback showed good 
dilation of the vessel with no significant dissection. 
Two EES were implanted (2.5 × 23, 3.0 × 30) 
and, due to some malposition in IVUS (Fig. 3M, N), 
post dilated with a 3.0 non-compliant balloon 
(Fig. 3O). IVUS-HD control showed optimal effect 
(Fig. 3P). Injection of 3.5 mL of contrast showed 
optimal effect of PCI (Fig. 3R). The patient was 
discharged after 2 days.
Patient 4. An 80-year-old male with ischemic 
systolic heart failure and CKD (eGFR 20 mL/ 
/min/1.73 m2), after numerous PCIs, after CRT-D 
implantation, was readmitted due to acute heart 
failure and electrical storm. Myocardial infarction 
was excluded. Echocardiographic assessment re-
vealed an LVEF of 20% and a significantly dilated 
left ventricle (LVEDD 78 mm). The patient was 
treated medically, requiring bilateral thoracentesis. 
After stabilization, due to recurrent ventricular 
tachycardia (VT), the patient was scheduled for 
coronary angiography. Significant LAD resteno-
sis was observed (Fig. 4A). After the procedure, 
further deterioration of renal function occurred 
(creatinine level 202 Æ 287 µmol/L) — treated with 
i.v. fluids. The patient was discussed by the Heart 
Team and qualified for zero contrast PCI. LAD 
was wired with a hydrophobic wire. As this was 
restenosis, an additional side branch wiring was 
not necessary. IVUS confirmed the presence of sig-
nificant restenosis with MLA of 2.2 mm2 (Fig. 4B). 
High-pressure dilation of the restenosis with a non-
compliant 3.0 balloon was performed, followed by 
3.0 paclitaxel eluting balloon inflations (Fig. 4C). 
Control IVUS revealed proper stent apposition and 
lumen dilation (postprocedural MLA of 4.5 mm2, 
Fig. 4D–F). No recurrence of VT was observed. 
The creatinine titers returned to prior levels (207 
µmol/L).
The patients were observed for a follow-up 
period of 12 months. Patients no. 1–3 had uncom-
plicated follow-up, not requiring further revascu-
larization and/or renal replacement therapy. Patient 
no. 4 had recurrent episodes of acute heart failure 
and subsequently died after 3 months and 9 days 
from index procedure, also with no need for further 
revascularization or renal replacement therapy.
This primary experience shows, that signifi-
cant experience in both PCI and IVUS can result 
in safe and effective IVUS-guided PCI procedures. 
The acceptance of ultra-low contrast quantity of 
contrast for final assessment may facilitate the 
introduction of these procedures in centers aim-
ing to implement a similar protocol for patients 
at extreme risk of contrast induced nephropathy.
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